Akorn, Inc. FDA Inspection Record

FEI 3003102962 · Inspections, Form 483s, warning letters and import refusals

Akorn, Inc. is an FDA-inspected facility (FEI 3003102962) located in Gurnee, IL, US. RegDataLab tracks 5 FDA inspections and 1 compliance action at this facility.

What FDA found at this site

Latest inspection
Mar 5, 2019: No Action Indicated (NAI)
Inspections on record
5 (1 VAI, 4 NAI)
Last OAI inspection
None on record
Warning letters
1 listed by FDA for this FEI, latest Oct 2, 2012
Form 483 and inspection documents
1 in FDA's reading room
Recalls as the recalling firm
55, latest Apr 26, 2023
Import refusals
1

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Mar 5, 2019No Action Indicated (NAI)No citations listed
Mar 20, 2017No Action Indicated (NAI)No citations listed
Feb 13, 2017No Action Indicated (NAI)No citations listed
Dec 18, 2015No Action Indicated (NAI)No citations listed
Nov 10, 2009Voluntary Action Indicated (VAI)Complaint Handling Procedure (21 CFR 211.198(a))
Complaint Investigation/Follow-Up Findings (21 CFR 211.198(b)(2))

Recalls

Showing the 10 most recent of 55 recalls. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Apr 26, 2023Class IID-0779-2023Atropine Sulfate Ophthalmic Solution, USP 1%, For Topical Application To The Eye, packaged… and 85 more products
CGMP Deviations: Firm went out of business and could no longer continue stability studies.
Jan 30, 2023Class IIID-0265-2023Atropine Sulfate Ophthalmic Solution, USP 1%, For Topical Application To The Eye, 2 mL…
Failed Stability Specifications: Out of specification test results for viscosity was identified at the 12M stability timepoint.
Oct 13, 2022Class IID-0132-2023AK-POLY-BAC brand of Bacitracin cand Polymixin B Sulfate Ophthalmic Ointment USP, 3.5 g… and 26 more products
CGMP Deviations:
Oct 13, 2022Class IIV-0034-2023Artificial tears, Lubricant ophthalmic ointment, For veterinary use, Net Wt. 3.5 g (1/8… and 6 more products
Manufacturing site is closing and subsequently discontinuing stability studies for all marketed products.
Sep 21, 2022Class IID-1547-2022Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Distributed by: Akorn Operating… and 1 more product
Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).
Aug 31, 2022Class IID-1495-2022Lidocaine Hydrochloride Jelly USP, 2%, Sterile, 30mL tube, Rx only, Manufactured by… and 1 more product
cGMP Deviations: Turbidity discovered in Artificial Tears Ointment during sterility testing. Scope expanded to include other lots and…
Aug 31, 2022Class IIV-0219-2022Ofloxacin Ophthalmic Solution, USP 0.3%, Sterile, Rx Only, 5 mL per dropper bottle…
Out of specification test results for impurity H (N-Oxide) in 23-month controlled room temperature stability samples.
Jun 13, 2022Class IID-1172-2022Fluticasone Propionate Nasal Spray, USP, 50 mcg, 16 g net fill weight per amber glass…
Defective container: defect prevents product from dispensing as intended.
Jun 10, 2022Class IID-1170-2022Calcipotriene Topical Solution, 0.005% (Scalp Solution), Rx only, 60 mL (2 fl. oz.)…
Defective Delivery System: Potential defect that could prevent the product from dispensing as intended.
Apr 15, 2022Class IIID-0846-2022Lidocaine Hydrochloride Oral Topical Solution, USP (Viscous) 2%, 100 mL per bottle, Rx…
Failed viscosity specification - product was below specificcation

Form 483s and inspection documents

  • 483 on FDA.gov
    Issued Nov 10, 2009 (dates printed on the document). FDA listing date Jul 11, 2015. Published by FDA Jan 18, 2024.

FDA record score

38 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

36 records behind this number
RecordDatePoints x age weightAdds
Class II recall D-0779-2023, this FEI as the recalling firmApr 26, 20234 x 0.62.4
Class II recall D-0132-2023, this FEI as the recalling firmOct 13, 20224 x 0.62.4
Class II recall V-0034-2023, this FEI as the recalling firmOct 13, 20224 x 0.62.4
Class II recall D-1547-2022, this FEI as the recalling firmSep 21, 20224 x 0.62.4
Class II recall D-1495-2022, this FEI as the recalling firmAug 31, 20224 x 0.62.4
Class II recall V-0219-2022, this FEI as the recalling firmAug 31, 20224 x 0.62.4
Class II recall D-1172-2022, this FEI as the recalling firmJun 13, 20224 x 0.62.4
Class II recall D-1170-2022, this FEI as the recalling firmJun 10, 20224 x 0.62.4
Class II recall D-0460-2022, this FEI as the recalling firmJan 5, 20224 x 0.62.4
Class II recall D-0004-2022, this FEI as the recalling firmOct 4, 20214 x 0.251
Class II recall D-0717-2022, this FEI as the recalling firmSep 8, 20214 x 0.251
Class II recall D-0802-2021, this FEI as the recalling firmAug 13, 20214 x 0.251
Class II recall D-0786-2021, this FEI as the recalling firmAug 2, 20214 x 0.251
Class II recall D-0301-2021, this FEI as the recalling firmMar 8, 20214 x 0.251
Class II recall D-0221-2021, this FEI as the recalling firmDec 28, 20204 x 0.251
Class II recall D-1628-2020, this FEI as the recalling firmSep 3, 20204 x 0.251
Class II recall D-0647-2020, this FEI as the recalling firmNov 15, 20194 x 0.251
Class II recall D-1883-2019, this FEI as the recalling firmSep 20, 20194 x 0.251
Class II recall D-1878-2019, this FEI as the recalling firmSep 17, 20194 x 0.251
Class II recall D-0993-2019, this FEI as the recalling firmFeb 22, 20194 x 0.251
Class II recall V-0140-2019, this FEI as the recalling firmFeb 21, 20194 x 0.251
Class II recall D-0414-2019, this FEI as the recalling firmOct 8, 20184 x 0.251
Class II recall D-1183-2018, this FEI as the recalling firmAug 24, 20184 x 0.251
Class II recall D-1046-2018, this FEI as the recalling firmAug 1, 20184 x 0.251
Class II recall D-0661-2017, this FEI as the recalling firmMar 17, 20174 x 0.251
Class II recall D-0949-2016, this FEI as the recalling firmMay 17, 201610 years or older, so it adds no points0
Class II recall D-0835-2016, this FEI as the recalling firmApr 7, 201610 years or older, so it adds no points0
Class II recall D-0874-2016, this FEI as the recalling firmMar 23, 201610 years or older, so it adds no points0
Class II recall D-1129-2015, this FEI as the recalling firmApr 7, 201510 years or older, so it adds no points0
Class II recall D-0995-2015, this FEI as the recalling firmMar 17, 201510 years or older, so it adds no points0
Class II recall D-0405-2015, this FEI as the recalling firmFeb 27, 201510 years or older, so it adds no points0
Class II recall D-0385-2015, this FEI as the recalling firmJan 28, 201510 years or older, so it adds no points0
Warning letter on FDA's dashboard, which does not show close-outsOct 2, 201210 years or older, so it adds no points0
Inspection classified VAINov 10, 200910 years or older, so it adds no points0
Class II recall D-049-2009, this FEI as the recalling firmJul 25, 200810 years or older, so it adds no points0
Class II recall D-081-4, this FEI as the recalling firmOct 27, 200310 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Akorn, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Akorn, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Akorn, Inc.
Location
Gurnee, IL (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.